Upgrades Also Include Integration with Apple Health, Manual Post-Workout Logging PLEASANTON, Calif. , March 10, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology and maker of the Evie Ring, today announced a series of new data personalization, trend tracking and integration features on the ring's companion app that expand support for women's wellness journeys. The enhancements follow January's... Read More

New proprietary RF hardware delivers significantly enhanced signal fidelity PLEASANTON, Calif. , Feb. 4, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that it has commenced a blood pressure clinical trial with its newly developed cuffless blood pressure wrist wearable. The study, which is expected to include at least 70 participants and be completed during the second week of February, utilizes the updated... Read More

Newest Evie Ring feature is the first medical journal trained AI companion in a wearable PLEASANTON, Calif. , Jan. 8, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) today announced the latest enhancement to its Evie smart ring for women with the beta release of EvieAI, the first wearable-based virtual wellness assistant trained exclusively with data from medical journals. The new feature enables Evie users to answer... Read More

PLEASANTON, Calif. , Jan. 2, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced the expansion of its board of directors with the addition of Dr. Shaheen Wirk , a leader in healthcare dedicated investment with a track record of success in medicine, partnerships, and research. With over 20 years of investment experience in public and private life science companies, Dr. Wirk is... Read More

Company's first 510(k) clearance unlocks a TAM of $40 billion in healthcare B2B opportunities PLEASANTON, Calif. , Dec. 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the pulse oximeter in its EvieMED Ring. The clearance enables Movano Health to pursue multi-billion dollar business opportunities for health... Read More

Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT / 5:00 PM ET Today PLEASANTON, Calif. , Nov. 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update. The Company continues to... Read More

New hardware boasts significant improvements to reduce noise and generate higher fidelity signals PLEASANTON, Calif. , Nov. 7, 2024 /PRNewswire/ -- Movano Health Inc . (Nasdaq: MOVE) announced today that it has tested its newly developed blood pressure wrist wearable as part of its November 5 th and 6 th hypoxia clinical trial that took place at the University of California, San Francisco . The updated device features an... Read More

Conference Call at 2:00 PM PT / 5:00 PM ET PLEASANTON, Calif. , Nov. 6, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report third quarter 2024 financial and operating results on Thursday November 14, 2024 , after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same... Read More

Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif. , Nov. 4, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) (the "Company") provided an update on an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split. Based on its... Read More

Company remains optimistic on the potential for this pioneering healthcare solution PLEASANTON, Calif. , Nov. 4, 2024 /PRNewswire/ -- Movano Health (NASDAQ: MOVE ) announced today that it has submitted a complete response package to the FDA as part of the final phase of the Company's 510(k) application review of the EvieMED Ring. The Company remains optimistic on EvieMED's potential for 510(k) clearance. "Our team has worked... Read More

Company Communicating with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif. , Oct. 31, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) (the "Company") announced today that it has opened an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split.... Read More

Collaboration Will Expand Awareness of Movano's Female First Wearable to D'Amelio's 12 Million Social Media Followers PLEASANTON, Calif. , Oct. 30, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) today announced its first brand partnership with digital creator, wife, mom and entrepreneur Heidi D'Amelio. An icon in the wellness, fashion and beauty space, D'Amelio will share her experiences with Movano's Evie Ring with her... Read More

Shares Expected to Begin Trading on Split-Adjusted Basis on October 29, 2024 PLEASANTON, Calif. , Oct. 25, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that it will implement a 1-for-15 reverse stock split of the issued shares of its common stock (the "Reverse Stock Split"), effective at 12:01 a.m. Eastern time on October 29, 2024 . The Company's common stock is expected to begin trading on a... Read More

A successful response to requests for additional information would bring the Company one step closer to introducing this pioneering healthcare product to the market PLEASANTON, Calif. , Oct. 24, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that it plans to submit updated responses next week to all clarifying questions that it recently received from the FDA as part of the final phase of the Company's... Read More

The Company continues to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Oct. 10, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that the Company recently received additional clarifying questions from the FDA related to medical aspects of the EvieMED Ring, as part of the final phase of the Company's 510(k) application review process. The Company secured... Read More

Orders Reopen with Enhancements to AI Powered Health Insights, Sleep and Heart Rate Measurements and More PLEASANTON, Calif. , Sept. 17, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) today announced the immediate availability of its Evie Ring , the first smart ring designed specifically for women. The ring features the same industry-first, award-winning open design that accommodates fluctuations in finger size, and is... Read More

Following the positive outcome of a recent agency meeting, the Company will continue to work closely with the FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Sept. 3, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) announced today that a productive in-person meeting with the FDA on August 15, 2024 , resulted in a positive outcome regarding the EvieMED Ring's wellness features and metrics.... Read More

Prepares for September 17, 2024 , Evie Ring back in stock date Announces brand partnership with digital creator Heidi D'Amelio Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT / 5:00 PM ET Today PLEASANTON, Calif. , Aug. 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported second quarter 2024 results and provided a business update. Following... Read More

Conference Call at 2:00 PM PT / 5:00 PM ET PLEASANTON, Calif. , Aug. 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report second quarter 2024 financial and operating results on Wednesday, August 14, 2024 , after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same... Read More

Company continues to work with FDA to bring this pioneering healthcare product to market PLEASANTON, Calif. , Aug. 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) plans to meet with the FDA in mid-August, as part of the Company's ongoing process to secure a 510(k) clearance for the EvieMED Ring, a wearable designed to not only provide medical device functionality through its pulse oximetry feature, but also offer... Read More

Allele Capitals' Matt Hughes will moderate future forward panel on enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif. , June 28, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced the addition of two expert participants to its B2B: The Next Wearables Boom Virtual Event to be held on July 11 – Dr. Fatima Rodriguez and Matt Hughes . Dr. Rodriguez and Mr. Hughes will join Movano... Read More

Enhancements address significant clinical enterprise need in wearables for a variety of healthcare applications PLEASANTON, Calif. , June 13, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE ) announced major advances in the accuracy of its heart rate in motion algorithm following the implementation of deep learning into the processing. The Company recently released an engineering accuracy study directed by Movano Health... Read More

Pioneering partnership advances innovative health monitoring, setting the stage for future enterprise opportunities. PLEASANTON, Calif. , June 10, 2024 /PRNewswire/ -- In a strategic move that could reshape the understanding of long COVID and chronic Lyme disease, the Massachusetts Institute of Technology ( MIT ) has forged a partnership with Movano Health for its MAESTRO study to harness the medical grade continuous health... Read More

Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance process Plans launch of Evie Med and focuses on B2B opportunities Plans arterial blood pressure study for June Conference Call at 2:00 PM PT / 5:00 PM ET Today PLEASANTON, Calif. , May 15, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported first quarter 2024 results and provided a business update. Following... Read More

Unlocking business-to-business opportunities with Evie Med, Movano Health's ring pulse oximeter, remains a key priority for the Company. PLEASANTON, Calif. , May 9, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced that it successfully submitted updated pivotal clinical trial results as well as proof of enhanced medical device usability on April 22, 2024 to the U.S. Food and Drug Administration (FDA) as part of its... Read More

Conference Call at 2:00 PM PT / 5:00 PM ET PLEASANTON, Calif. , May 6, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report first quarter 2024 financial and operating results on Wednesday May 15, 2024 , after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same day at... Read More

Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from insiders including members of Movano Health's management team and board of directors PLEASANTON, Calif. , April 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, has closed on a $24.1 million private placement, totaling 45.3 million units, with each unit consisting... Read More

Executes $24 million funding extending cash runway Focuses on 2024 strategic pathway to FDA clearances driving B2B opportunities Plans launch of Evie Med Conference Call at 2:00 PM PT / 5:00 PM ET Today PLEASANTON, Calif. , April 4, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported fourth quarter and year end 2023 results and provided a business update. This week, Movano Health... Read More

Financing included a strategic seed investment by a tier-1 multi-billion dollar medical device company and participation from members of Movano Health's management team and board of directors Hosting conference call on April 4, 2024 at 2:00 PM PT / 5:00 PM ET PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today has agreed to sell approximately 45 million units... Read More

The seed investment and agreement underscores Movano Health's multi-analyte and proprietary mmWave radio frequency technology PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, secured a strategic investment from a tier-one multi-billion dollar medical device company and signed an agreement to explore future collaborations relating to development and... Read More

Conference Call at 2:00 PM PT / 5:00 PM ET PLEASANTON, Calif. , April 2, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that it will report fourth quarter 2023 financial and operating results on Thursday, April 4, 2024 , after the market close. Management will host a conference call and live audio webcast to discuss these results and provide a business update on the same... Read More

PLEASANTON, Calif. , March 14, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, has completed another hypoxia trial with the University of California, San Francisco (UCSF) yielding new blood oxygen saturation (SpO2) data, confirming the accuracy of its Evie Ring pulse oximeter exceeds the U.S. Food and Drug Administration (FDA) guidelines. The Evie Ring entered commercial production in late... Read More

PLEASANTON, Calif. , Jan. 22, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, announced that its female first wearable, the Evie Ring, will begin shipping today. "This milestone marks the culmination of an incredible journey of hard work, dedication, and innovation," said John Mastrototaro ,... Read More

LAS VEGAS , Jan. 9, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, and ams OSRAM, a leader in technology for biometric monitoring, have collaborated to include ams OSRAMs PPG sensor solution in the Evie Ring, Movano Health's smart ring designed specifically for women. With the goal to bring high-quality data to the forefront of consumer health devices, Movano Health´s female-first... Read More

Movano Health's 2024 CES Innovation Honoree Ships This Month LAS VEGAS , Jan. 8, 2024 /PRNewswire/ -- The Evie Ring from Movano Health (Nasdaq: MOVE), the market's first women-focused smart ring , is redefining the wearable category with a unique band design, female-specific data interpretation, and AI-based trend analysis that goes beyond raw activity scores to improve users' ability to understand and manage their health.... Read More

PLEASANTON, Calif. , Dec. 18, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that its female first wearable, the Evie Ring, is now eligible for HSA/FSA fund reimbursement. "Securing eligibility for HSA/FSA fund reimbursement is tantamount to our goal of making the Evie Ring accessible to as many women as possible," said John Mastrototaro , CEO of Movano Health. "We are... Read More

PLEASANTON, Calif. , Dec. 12, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that following the successful results of its recent blood pressure clinical trial it will be holding in person demonstrations of live waveforms at both the 2024 CES Show in Las Vegas January 8-11,... Read More

PLEASANTON, Calif. , Dec. 5, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that the Evie Ring, the smart ring designed specifically for women's health, has received a 2024 CES Innovation Honoree Award in the wearables category. The Evie Ring is a valuable new tool for women seeking to take control of their health. Its innovative form factor designed for women's fingers, focus on helping women track and... Read More

PLEASANTON, Calif. , Nov. 29, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announces the successful ecommerce launch of the Evie Ring, the innovative smart ring designed for women, which has exceeded the Company's commercial sales goals driving over $1 million in orders through the Thanksgiving Holiday. "We were very pleased to see the exceptional conversion rates for the Evie... Read More

Unique Design, Women-Focused Metrics and Cross-Data Trend Analysis Set a New Bar for Wearables PLEASANTON, Calif. , Nov. 20, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) begins taking orders for the Evie Ring , the smart ring designed specifically for women, today at 12 pm EST . An innovative and comfortable form factor,... Read More

PLEASANTON, Calif. , Nov. 17, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced the closing of its $4.1 million underwritten public offering of 4,870,600 shares of its common stock, including 635,296 shares of its common stock issued pursuant to the... Read More

Conference call begins at 8:30 a.m. Pacific time today PLEASANTON, Calif. , Nov. 15, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, reported financial results for the three months ending September 30, 2023 and provided a business update. Key highlights from the third quarter and recent... Read More

PLEASANTON, Calif. , Nov. 15, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it has priced a $3.6 million underwritten public offering of 4,235,304 shares of its common stock. The public offering price, before the underwriters' discount and... Read More

Reschedules Q3 results conference call to 11:30 am EST on November 15, 2023 PLEASANTON, Calif. , Nov. 14, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring , today announced that, in light of the Company's recently announced proposed common stock offering, Movano Health has issued its... Read More

PLEASANTON, Calif. , Nov. 14, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it is proposing to sell shares of its common stock in an underwritten public offering. All of the shares of common stock in the underwritten public offering are to... Read More

PLEASANTON, Calif. , Nov. 3, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring , today announced that it will report third quarter 2023 financial and operating results on Tuesday, November 14, 2023. Management will host a conference call and live audio webcast to discuss these results... Read More

Leveraging the Company's 4 x 6.7 mm System-on-a-Chip (SoC), the clinical study results are a significant step forward in commercializing a cuffless, radio frequency (RF)-enabled blood pressure device PLEASANTON, Calif. , Oct. 31, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced the... Read More

The Company will begin taking orders for the smart ring designed for women's health through its commercial site www.eviering.com in time for Black Friday PLEASANTON, Calif. , Oct. 30, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced its launch plans for the Evie Ring, the smart... Read More

Dr. Rodriguez will provide strategic input and medical validation to guide innovation for the Evie Ring PLEASANTON, Calif. , Sept. 12, 2023 /PRNewswire/ -- After recently announcing the establishment of its Medical Advisory Board , Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today shared Dr. Fátima Rodriguez has... Read More

The Evie Ring, the first medical grade health wearable designed for women, will ship from FDA registered fulfillment provider Jay Group LANCASTER, Pa. , Aug. 30, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced the selection of advanced fulfillment provider, Jay Group , as its 3PL.... Read More

Conference call begins at 2:00 p.m. Pacific time today PLEASANTON, Calif. , Aug. 14, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , reported financial results for the three months ending June 30, 2023 and provided a business update. Key highlights from the second quarter and recent weeks... Read More

The women-led board will leverage their medical and scientific expertise to enhance Evie's product roadmap and provide trusted content PLEASANTON, Calif. , Aug. 10, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , announced the formation of its Medical Advisory Board. The initial panel is... Read More

PLEASANTON, Calif. , Aug. 8, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring , today announced that it will report second quarter 2023 financial and operating results on Monday, August 14, 2023 . Management will host a conference call and live audio webcast to discuss these results... Read More

The 510(k) application covers Evie Ring's pulse oximeter that includes heart rate and SpO2 data, and is expected to make it one of the first consumer wearables that is also cleared for clinical use PLEASANTON, Calif. , Aug. 3, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , announced that... Read More

PLEASANTON, Calif. , June 15, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced the closing of its $9.2 million underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares of its common stock issued pursuant to... Read More

PLEASANTON, Calif. , June 13, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it has priced an $8.0 million underwritten public offering of 8,000,000 shares of its common stock. The public offering price, before the underwriters' discount... Read More

PLEASANTON, Calif. , June 12, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it is proposing to sell shares of its common stock in an underwritten public offering. All of the shares of common stock in the underwritten public offering are to... Read More

Conference call begins at 9:00 a.m. Pacific time today PLEASANTON, Calif. , May 15, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , reported financial results for the three months ending March 31, 2023 and provided a business update. Key highlights from the first quarter and recent weeks... Read More

PLEASANTON, Calif. , April 24, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring , today announced that it will report first quarter 2023 financial and operating results on Monday, May 15, 2023 . Management will host a conference call and live audio webcast to discuss these results and... Read More

Conference call begins at 9:00 a.m. Pacific time today PLEASANTON, Calif. , March 20, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , reported financial results for the three months and year ending December 31, 2022 and provided a business update. Key highlights from the fourth quarter and... Read More

Company developed its proprietary radio frequency technology to improve upon accuracy, cost and the size of wearable health technology PLEASANTON, Calif. , March 14, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, has been granted three new patents (2 US; 1 China) further safeguarding the... Read More

Movano Health's survey of 1,000 U.S. women reveals that accuracy of data is a critical feature for those considering a wearable to help them manage health. The company is eyeing an FDA clearance submission for its Evie Ring to give consumers a higher level of trust in their health data. PLEASANTON, Calif. , March 7, 2023... Read More

PLEASANTON, Calif. , Feb. 23, 2023 /PRNewswire/ -- Movano Inc. (NASDAQ: MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring , today announced that it will report fourth quarter 2022 financial and operating results on Monday, March 20, 2023. Management will host a conference call and live audio webcast to discuss these results... Read More

PLEASANTON, Calif. , Feb. 6, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it has completed a $7.5 million underwritten public offering of 5,340,600 shares of its common stock and warrants to purchase up to 2,670,300 shares of common stock, including the full exercise of... Read More

PLEASANTON, Calif. , Jan. 27, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it has priced a $6.5 million underwritten public offering of 4,644,000 shares of its common stock and warrants to purchase up to 2,322,000 shares of common stock. The warrants are being sold at the... Read More

PLEASANTON, Calif. , Jan. 26, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring , today announced that it is proposing to sell shares of its common stock and warrants to purchase common stock in an underwritten public offering. All of the shares in the underwritten public offering are to be sold by... Read More

On the heels of a successful brand announcement, the Company was also awarded five new patents, increasing its intellectual property portfolio to 18 total issued patents PLEASANTON, Calif. , Jan. 17, 2023 /PRNewswire/ -- At the 2023 Consumer Electronics Show (CES), Movano Health (Nasdaq: MOVE), a purpose-driven healthcare... Read More

Company plans to file for FDA clearance of a new wearable that provides women with medical grade data and personalized actionable insights to track and manage overall health PLEASANTON, Calif. , Dec. 28, 2022 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of... Read More

Preliminary results demonstrated high accuracy of SpO 2 and heart rate data in its pivotal hypoxia trial, bringing the Company one step closer to developing a medical device PLEASANTON, Calif. , Dec. 14, 2022 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices , today announces successful preliminary results of its pivotal hypoxia... Read More

The beta program is designed to advance the development of Movano Health's comprehensive health data monitoring solution WINSTON-SALEM, N.C. and PLEASANTON, Calif. , Dec. 13, 2022 /PRNewswire/ -- Today, Novant Health , a not-for-profit integrated system of medical centers with more than 1,800 physicians providing care through six million annual patient visits at nearly 800 locations across North Carolina , South Carolina and... Read More